Product Description
Dolutegravir Spegra Tablets are an acclaimed pharmaceutical solution, formulated using a celebrated combination of Dolutegravir, Tenofovir Alafenamide, and Emtricitabine. These trending, prime tablets are crafted for the ephemeral yet critical management of HIV-1 infection, suitable for both adults and pediatric patients. Renowned for their lofty efficacy and consistency, each film-coated tablet is meticulously manufactured in India to the highest industry standards. Only available with a prescription, this product marks a significant leap in HIV treatment, offering 30 tablets per carton with optimal storage below 30C.
Key Features & Applications of Dolutegravir Spegra Tablets
Dolutegravir Spegra Tablets exemplify advanced pharmaceutical machinery in their precise, film-coated formulation. Primarily used for the management and control of HIV-1 infection, these tablets demonstrate superior stability and bioavailability. Suitable for both adult and pediatric applications, they are designed for ease of oral administration. Their plant application involves stringent pharmaceutical protocols, ensuring only top-grade, celebrated medications reach patients requiring effective antiretroviral therapy in India.
FOB Port, Certifications, and Sample Policy Details
Dolutegravir Spegra Tablets are available for dispatching at the lowest price via major Indian FOB ports. We prioritize prompt drop-off and delivery arrangements to meet supply demands. Each batch undergoes comprehensive certification processes to ensure international pharmaceutical standards are achieved. For new clients, our transparent sample policy allows for preliminary evaluation before large orders. This celebrated export solution reinforces our commitment to quality assurance and timely distribution.
FAQ's of Dolutegravir Spegra Tablets:
Q: How should Dolutegravir Spegra Tablets be stored?
A: Store Dolutegravir Spegra Tablets below 30C in their original packaging to maintain product integrity and efficacy throughout their shelf life.
Q: What is the benefit of using Dolutegravir Spegra Tablets for HIV-1 infection?
A: Dolutegravir Spegra Tablets provide a prime, effective approach to managing and controlling HIV-1 infection, combining three celebrated antiretroviral agents to optimize viral suppression in adults and children.
Q: When is a prescription required for Dolutegravir Spegra Tablets?
A: A valid doctor's prescription is always needed before purchasing or using Dolutegravir Spegra Tablets, ensuring proper medical supervision and appropriate therapy.
Q: Where are Dolutegravir Spegra Tablets manufactured and exported from?
A: These tablets are manufactured and supplied in India, with export capabilities to approved regions and stringent compliance with pharmaceutical regulations.
Q: What process is followed to ensure the quality of Dolutegravir Spegra Tablets?
A: Every batch undergoes rigorous quality checks, is certified per pharmaceutical standards, and is dispatched only upon meeting all regulatory criteria to guarantee patient safety and product potency.
Q: How is the dosage determined for Dolutegravir Spegra Tablets?
A: The recommended dosage is 50/200/25 mg per tablet, as directed by a healthcare professional based on individual patient requirements for HIV-1 infection management.
Send Inquiry
Send Inquiry
Send SMS
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese